1. Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma
    DONG DAI et al, 2013 CrossRef
  2. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
    Thomas Tu et al, 2014, IJMS CrossRef
  3. The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.
    Lijuan Xiong et al, 2014, Int J Mol Sci CrossRef
  4. Avicequinone B sensitizes anoikis in human lung cancer cells
    Arisara Prateep et al, 2018, J Biomed Sci CrossRef
  5. Estrogen receptor positive breast tumors resist chemotherapy by the overexpression of P53 in Cancer Stem Cells
    Fatma Ashour et al, 2018, Journal of the Egyptian National Cancer Institute CrossRef
  6. Structural insights on druggable hotspots in CD147: A bull's eye view
    Dhivya Kumar et al, 2019, Life Sciences CrossRef
  7. Necrobiology of Liver Cancer: Other Forms of Cell Death Related or not Related to Apoptosis
    Arthur Zimmermann, 2016 CrossRef
  8. Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia
    Xia Ke et al, 2014, Hepatol Int CrossRef
  9. Effects of HAb18G/CD147 Knockout on Hepatocellular Carcinoma Cells In Vitro Using a Novel Zinc-Finger Nuclease-Targeted Gene Knockout Approach
    Hong-Wei Li et al, 2015, Cell Biochem Biophys CrossRef
  10. Necrobiology of Liver Cancer: Other Forms of Cell Death Related or Not Related to Apoptosis
    Arthur Zimmermann, 2017 CrossRef
  11. Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.
    Pei-yuan Li, 0 CrossRef
  12. CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker.
    Alexandra Landras et al, 2019, Cancers (Basel) CrossRef
  13. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters
    Xiaofeng Li et al, 2016, Oncotarget CrossRef
  14. The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells
    Zhenhua Hu et al, 2016, Oncotarget CrossRef
  15. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling
    Bao-Qing Xu et al, 2016, Oncotarget CrossRef
  16. Detachment Activated CyPA/CD147 Induces Cancer Stem Cell Potential in Non-stem Breast Cancer Cells.
    Yao Meng et al, 2020, Front Cell Dev Biol CrossRef
  17. HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
    Ling Li et al, 2013, Clin Cancer Res CrossRef
  18. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.
    Christopher Gromisch et al, 2020, Cancer Res CrossRef
  19. LncRNA influence sequential steps of hepatocellular carcinoma metastasis
    Enjun Lv et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  20. Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin
    Rifei Li et al, 2022, Front. Immunol. CrossRef
  21. The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview.
    Giovanni Barillari, 0 CrossRef
  22. β2-Adrenoceptor Activation Favor Acquisition of Tumorigenic Properties in Non-Tumorigenic MCF-10A Breast Epithelial Cells
    Dany Silva et al, 2024, Cells CrossRef